@article{007d2b44207545fdb78585609b70b99f,
title = "The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation",
abstract = "BACKGROUND & AIMS: This study aimed to assess the real-life clinical and virological outcomes of HCV waitlisted patients for liver transplantation (LT) who received sofosbuvir/ribavirin (SOF/R) within the Italian compassionate use program.METHODS: Clinical and virological data were collected in 224 patients with decompensated cirrhosis and/or hepatocellular carcinoma (HCC) receiving daily SOF/R until LT or up a maximum of 48 weeks.RESULTS: Of 100 transplanted patients, 51 were HCV-RNA negative for >4 weeks before LT (SVR12: 88%) and 49 negative for ",
keywords = "Journal Article",
author = "Silvia Martini and Donato, {Maria Francesca} and Chiara Mazzarelli and Maria Rendina and Ubaldo Visco-Comandini and Daniela Fil{\`i} and Alice Gianstefani and Stefano Fagiuoli and Mario Melazzini and Simona Montilla and Luca Pani and Sandra Petraglia and Pierluigi Russo and Trotta, {Maria Paola} and Paola Carrai and Paolo Caraceni and group, {ITACOPS study}",
note = "{\textcopyright} 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2017",
month = sep,
day = "16",
doi = "10.1111/liv.13588",
language = "English",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
}